Editorials

RBM15 and ZMYND8 shape acute myeloid leukemia response to BCL2 inhibitors

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Ann Arbor
Haematologica Early view Apr 16, 2026 https://doi.org/10.3324/haematol.2025.288972